Research direction
Tumor Immunology & Immunoprevention
Immune surveillance shapes cancer development long before clinical manifestation. We investigate how tumor-associated antigens trigger immune responses, how immune selection influences tumor evolution, and how emerging clones evade recognition. Understanding these interactions provides the foundation for developing immune-based strategies for cancer prevention and therapeutic intervention.